Ecolab combines 90% recurring revenue and pricing power with a high-growth AI-cooling option, but 34x earnings and CoolIT leverage demand disciplined execution.
Overview
Ecolab is the global benchmark in water, hygiene, infection prevention, and pest-elimination solutions. Its integrated chemistry, hardware, digital monitoring, and on-site service model makes customer operations more reliable while generating highly recurring revenue: consumables and multi-year services represent approximately **90% of consolidated sales**. North America contributes about 55% of revenue, Europe 22%, and Global Water is the largest segment at roughly 49% of sales. Q2 fiscal 2026 demonstrated improving momentum, with sales up 9.7% year over year to $4.42 billion, organic growth of 5.0%, adjusted EPS of $2.09, and GAAP EPS of $1.90. Management raised fiscal 2026 adjusted EPS guidance to $8.05–$8.25, or 7%–10% growth. The investment case combines resilient core demand with the potentially transformational CoolIT and Ovivo acquisitions, although integration and leverage are meaningful constraints. At approximately **34x forward earnings**, Ecolab is expensive relative to conventional chemical peers but supported by recurring cash flow, pricing power, and AI data-center exposure. Near-term catalysts include 5%–6% second-half pricing, the 20% operating-margin target for 2027, and continued High-Tech and Life Sciences growth.